Network Pharmacology Combined with Proteomics Reveals That 3‑Acetyl-11-keto-β-boswellic Acid Inhibits the Progression of Prostate Cancer by Regulating the IL-17 Signaling Pathway

Saved in:
Bibliographic Details
Main Authors: Bo Zou, Qizhi Liu, Yan Long, Xinjun Dai, Xuefei Tian, Qing Zhou
Format: Article
Language:English
Published: American Chemical Society 2025-05-01
Series:ACS Omega
Online Access:https://doi.org/10.1021/acsomega.5c01683
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850156759186931712
author Bo Zou
Qizhi Liu
Yan Long
Xinjun Dai
Xuefei Tian
Qing Zhou
author_facet Bo Zou
Qizhi Liu
Yan Long
Xinjun Dai
Xuefei Tian
Qing Zhou
author_sort Bo Zou
collection DOAJ
format Article
id doaj-art-90feb08b2ee045fbbe19a53d6288f31f
institution OA Journals
issn 2470-1343
language English
publishDate 2025-05-01
publisher American Chemical Society
record_format Article
series ACS Omega
spelling doaj-art-90feb08b2ee045fbbe19a53d6288f31f2025-08-20T02:24:25ZengAmerican Chemical SocietyACS Omega2470-13432025-05-011021218132182210.1021/acsomega.5c01683Network Pharmacology Combined with Proteomics Reveals That 3‑Acetyl-11-keto-β-boswellic Acid Inhibits the Progression of Prostate Cancer by Regulating the IL-17 Signaling PathwayBo Zou0Qizhi Liu1Yan Long2Xinjun Dai3Xuefei Tian4Qing Zhou5The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, ChinaHunan University of Chinese Medicine, Changsha, Hunan, ChinaThe First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, ChinaLiuyang Hospital of Traditional Chinese Hospital, Changsha, Hunan, ChinaHunan University of Chinese Medicine, Changsha, Hunan, ChinaThe First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, Chinahttps://doi.org/10.1021/acsomega.5c01683
spellingShingle Bo Zou
Qizhi Liu
Yan Long
Xinjun Dai
Xuefei Tian
Qing Zhou
Network Pharmacology Combined with Proteomics Reveals That 3‑Acetyl-11-keto-β-boswellic Acid Inhibits the Progression of Prostate Cancer by Regulating the IL-17 Signaling Pathway
ACS Omega
title Network Pharmacology Combined with Proteomics Reveals That 3‑Acetyl-11-keto-β-boswellic Acid Inhibits the Progression of Prostate Cancer by Regulating the IL-17 Signaling Pathway
title_full Network Pharmacology Combined with Proteomics Reveals That 3‑Acetyl-11-keto-β-boswellic Acid Inhibits the Progression of Prostate Cancer by Regulating the IL-17 Signaling Pathway
title_fullStr Network Pharmacology Combined with Proteomics Reveals That 3‑Acetyl-11-keto-β-boswellic Acid Inhibits the Progression of Prostate Cancer by Regulating the IL-17 Signaling Pathway
title_full_unstemmed Network Pharmacology Combined with Proteomics Reveals That 3‑Acetyl-11-keto-β-boswellic Acid Inhibits the Progression of Prostate Cancer by Regulating the IL-17 Signaling Pathway
title_short Network Pharmacology Combined with Proteomics Reveals That 3‑Acetyl-11-keto-β-boswellic Acid Inhibits the Progression of Prostate Cancer by Regulating the IL-17 Signaling Pathway
title_sort network pharmacology combined with proteomics reveals that 3 acetyl 11 keto β boswellic acid inhibits the progression of prostate cancer by regulating the il 17 signaling pathway
url https://doi.org/10.1021/acsomega.5c01683
work_keys_str_mv AT bozou networkpharmacologycombinedwithproteomicsrevealsthat3acetyl11ketobboswellicacidinhibitstheprogressionofprostatecancerbyregulatingtheil17signalingpathway
AT qizhiliu networkpharmacologycombinedwithproteomicsrevealsthat3acetyl11ketobboswellicacidinhibitstheprogressionofprostatecancerbyregulatingtheil17signalingpathway
AT yanlong networkpharmacologycombinedwithproteomicsrevealsthat3acetyl11ketobboswellicacidinhibitstheprogressionofprostatecancerbyregulatingtheil17signalingpathway
AT xinjundai networkpharmacologycombinedwithproteomicsrevealsthat3acetyl11ketobboswellicacidinhibitstheprogressionofprostatecancerbyregulatingtheil17signalingpathway
AT xuefeitian networkpharmacologycombinedwithproteomicsrevealsthat3acetyl11ketobboswellicacidinhibitstheprogressionofprostatecancerbyregulatingtheil17signalingpathway
AT qingzhou networkpharmacologycombinedwithproteomicsrevealsthat3acetyl11ketobboswellicacidinhibitstheprogressionofprostatecancerbyregulatingtheil17signalingpathway